Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
1995-9-5
pubmed:abstractText
The t(8;21) is a frequent chromosome abnormality in acute myeloid leukemia (AML), particularly associated with M2 of the French-American-British (FAB) classification, but also found in a few patients with myelodysplastic syndrome (MDS). The two genes involved in the t(8;21) have been recently isolated and the cDNA of the AML1/ETO fusion gene identified. We have investigated a series of AML and MDS patients by a reverse transcriptase-polymerase chain reaction (RT-PCR) and analyzed the clinical and laboratory features of leukemia with t(8;21). The t(8;21) was only found in a subset of M2, which had the clinical and hematological features distinct from those M2 without t(8;21). M2 with t(8;21) was associated with a significantly higher myeloid differentiation and with a good response to chemotherapy. Moreover, among the patients with refractory anemia with excess of blasts in transformation (RAEB-T) the t(8;21) was also significantly associated with a higher myeloid differentiation and a good response to chemotherapy. M2 patients with t(8;21) could be distinguished on a number of hematological parameters, eg white blood cell count and percentage of bone marrow myeloblasts and promyelocytes, from RAEB-T carrying the t(8;21). Based on these findings we suggest that leukemia patients carrying t(8;21) can be grouped into two types; overt acute myeloid leukemia (M2) and smoldering or slowly evolving myeloid leukemia.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0887-6924
pubmed:author
pubmed:issnType
Print
pubmed:volume
9
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1147-53
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:7630188-Adolescent, pubmed-meshheading:7630188-Adult, pubmed-meshheading:7630188-Aged, pubmed-meshheading:7630188-Anemia, Refractory, with Excess of Blasts, pubmed-meshheading:7630188-Base Sequence, pubmed-meshheading:7630188-Bone Marrow, pubmed-meshheading:7630188-Cell Differentiation, pubmed-meshheading:7630188-Chromosomes, Human, Pair 21, pubmed-meshheading:7630188-Chromosomes, Human, Pair 8, pubmed-meshheading:7630188-Core Binding Factor Alpha 2 Subunit, pubmed-meshheading:7630188-DNA-Binding Proteins, pubmed-meshheading:7630188-Female, pubmed-meshheading:7630188-Granulocytes, pubmed-meshheading:7630188-Humans, pubmed-meshheading:7630188-Leukemia, Myeloid, Acute, pubmed-meshheading:7630188-Leukocytosis, pubmed-meshheading:7630188-Male, pubmed-meshheading:7630188-Middle Aged, pubmed-meshheading:7630188-Molecular Sequence Data, pubmed-meshheading:7630188-Neoplasm Proteins, pubmed-meshheading:7630188-Oncogene Proteins, Fusion, pubmed-meshheading:7630188-Polymerase Chain Reaction, pubmed-meshheading:7630188-Proto-Oncogene Proteins, pubmed-meshheading:7630188-Transcription Factors, pubmed-meshheading:7630188-Translocation, Genetic
pubmed:year
1995
pubmed:articleTitle
High degree of myeloid differentiation and granulocytosis is associated with t(8;21) smoldering leukemia.
pubmed:affiliation
Second Department of Internal Medicine, Kumamoto University School of Medicine, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't